Riluzole (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Riluzole drug offered from Mylan Pharmaceuticals Inc.. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: riluzole
SUBSTANCE NAME: RILUZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-07-22
END MARKETING DATE: 0000-00-00


Riluzole HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRiluzole from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2013-07-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-4145_75702b86-50cd-45e7-9884-355e02aa8c8a
PRODUCT NDC: 0378-4145
APPLICATION NUMBER: ANDA203042

Other RILUZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingRILUZOLE
Apotex CorpRILUZOLE
Ascend Laboratories, LLCRiluzole
Covis PharmaRilutek
Covis Pharmaceuticals, Inc.Rilutek
Glenmark Pharmaceuticals Inc., USAriluzole
KAISER FOUNDATION HOSPITALSRilutek
Mylan Pharmaceuticals Inc.Riluzole
Rising Pharmaceuticals, Inc.Riluzole
sanofi-aventis U.S. LLCRilutek
Sun Pharmaceutical Industries LimitedRiluzole